RareCyte
Business Services · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2601 4th Ave Ste 500, Seattle, Washingto...Phone Number
(206) 455-9092Website
www.rarecyte.comRevenue
$15.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About RareCyte
RareCyte innovative life science company that has develops technologies for the analysis of rare single cells in blood. Established in 2009, RareCyte is headquartered in Seattle, Washington.Explore more
RareCyte Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RareCyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
RareCyte, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once RareCyte has new funding data
Check if RareCyte has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on RareCyte recently announced quarterly report
Check out if RareCyte is spiking on competitors!
Product Launch: Get notified when RareCyte launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at RareCyte
Click to see if RareCyte had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined RareCyte as Masked Content
Find more new buyers
Compare Similar Companies to RareCyte
Compare insights from companies similar to RareCyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RareCyte is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
RareCyte is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about RareCyte.
RareCyte financials insights
Gather financial insights about RareCyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Private Equity
$30M
2019
Unspecified
$22M
2020
Debt
$1M
2021
Unspecified
$24M
2024
Other Financing Round
$20M
RareCyte Tech Stack
A closer look at the technologies used by RareCyte
See more technologies
Most Recent Scoops
Open Position
Person-Based
Business Intelligence, Analytics & Insights, Clinical Operations
Event
Product Marketing, Events, Research & Development, Bioengineering, Medical Research, Clinical Operations, Healthcare Technology
Funding
Open Position
RareCyte News & Media
RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services
SEATTLE, June 27, 2024 /PRNewswire/ -- RareCyte, Inc. ("RareCyte" or "the Company") a Life Sciences company providing advanced Precision Biology platforms including instruments, reagents, software, and services announced today the completion of a $20M financing from new and existing...Navigate BioPharma Services, Inc. announces collaboration with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion™ Platform
CARLSBAD, Calif., April 9, 2024 /PRNewswire/ -- Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications announces the launch of its new multiplex spatial...SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio
RareCyte will use the SOPHiA DDM™ Platform to support its oncology testing panel BOSTON and ROLLE, Switzerland, Jan. 18, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that RareCyte Inc., a...Recent Nature publications highlight the groundbreaking performance of RareCyte's Orion Spatial Biology platform
SEATTLE, Sept. 26, 2023 /PRNewswire/ -- In the exciting, growing field of Spatial Biology, the Orion platform from RareCyte has emerged as the platform of choice across biomarker discovery, translational and clinical research. Recent publications of pioneering findings in Nature journals,...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RareCyte
Sign Up For FreeTo access detailed company insights
RareCyte innovative life science company that has develops technologies for the analysis of rare single cells in blood. Established in 2009, RareCyte is headquartered in Seattle, Washington.... Read More
